Showing results (221-230 of 319) with videos related to

Sort By:
Pageof 32
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|July 3, 1998
[Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides]K Waisser, L Kubicová, J Gregor, et al.
Eye (London, England)|July 31, 1998
The use of corticosteroids for choroidal neovascularisation in young patientsC J Flaxel, S L Owens, B Mulholland, et al.
European Journal of Pharmacology|March 23, 2004
8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodentsPeter B Hedlund, Lisa Kelly, Curt Mazur, et al.
Fortschritte Der Neurologie-Psychiatrie|October 23, 1998
[Quantitative assessment of brain morphology with CT in agoraphobia]C Wurthmann, J Gregor, A Schwarz, et al.
Retina (Philadelphia, Pa.)|July 17, 2008
Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edemaSobha Sivaprasad, Zoe Ockrim, Panos Massaoutis, et al.
Vnitrni Lekarstvi|January 1, 1989
[Long-term study of disorders of heart rhythm in patients with chronic diseases of the respiratory system]B Král, P Tilser, J Gregor, et al.
The British Journal of Ophthalmology|March 19, 2005
Angiopoietin concentrations in diabetic retinopathyJ I Patel, P G Hykin, Z J Gregor, et al.
The British Journal of Ophthalmology|September 30, 1999
Retained intravitreal lens fragments after phacoemulsification: a clinicopathological correlationL M Yeo, D G Charteris, C Bunce, et al.
Clinical Therapeutics|June 27, 2000
Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con OlanzapinaJ A Sacristán, J C Gómez, A L Montejo, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 23, 2001
Influence of the replacement of the oxo function with the thioxo group on the antimycobacterial activity of 3-aryl-6,8-dichloro-2H-1,3-benzoxazine-2,4(3H)-diones and 3-arylquinazoline-2,4(1H,3H)-dionesK Waisser, J Gregor, H Dostál, et al.
Pageof 32